The neural cell adhesion molecule (NCAM) is a membrane-associated member of the immunoglobulin superfamily capable of both homophilic and heterophilic binding. To investigate the significance of this binding, a gene targeting strategy in embryonic stem (ES) cells was used to replace the membrane-associated forms of NCAM with a soluble, secreted form of its extracellular domain. Although the heterozygous mutant ES cells were able to generate low coat color chimeric mice, only the wild-type allele was transmitted, suggesting the possibility of dominant lethality. Analysis of chimeric embryos with high level of ES cell contribution revealed severe growth retardation and morphological defects by E8.5-E9.5. The second allele was also targeted, and embryos derived almost entirely from the homozygous mutant ES cells exhibited the same lethal phenotype as observed with heterozygous chimeras. Together, these results indicate that dominant lethality associated with the secreted NCAM does not require the presence of membrane-associated NCAM. Furthermore, the data indicate that potent bioactive cues or signals can be generated by NCAM.
The neural cell adhesion molecule (NCAM) is a membranebound immunoglobulin superfamily glycoprotein that plays a role in cell-cell and cell-matrix adhesion through both its homophilic and heterophilic binding activity (1) . Targeted mutations in the Ncam gene have been produced in embryonic stem (ES) cells to generate mutant mice in which the in vivo function of NCAM can be evaluated. The first two animals generated, a null mutation and a deletion of one of the major NCAM isoforms, were both viable and fertile, with no phenotype evident by casual observation (2, 3) . However, more intensive analysis revealed localized and distinct defects in the central nervous system including the morphology of the subventricular zone, olfactory bulb, cerebellum, retina, and hippocampus (3) . Other aspects of the phenotype remain to be discovered and studied, but also are likely to represent localized alterations in tissue structure.
In this study we employed the same genetic approach to a different purpose, namely to examine the effects of NCAMbinding events through the generation of a soluble and secreted form of the extracellular domain of the molecule. Furthermore, the use of homologous recombination to generate the secreted form has provided the opportunity to examine these effects in the absence of the membraneassociated forms. The findings indicate that abnormal NCAM expression is capable of generating drastic malformations that were not apparent from either the null or the NCAM180 isoform mutations (2, 3) . Proc. Natl. Acad. Sci. USA 93 (1996) Wild-type embryos were then washed in PBS and stored in methanol for from 24 hr to 2 weeks at 4°C. The embryos were rehydrated through an ethanol series into PBS and then washed twice for 30 min each. The embryos were incubated for 30 min in 1 M glycine (pH 7-8) and washed in PBS, then incubated in PBS plus 3% H202 for 10 min, followed by four washes (1 x PBS/0.2% BSA/0.1% Tween 20) 30 min each, and then placed in dilution buffer (1 x PBS/0.2% BSA/0.1% Tween 20/1% fetal calf serum) for 30 min, followed by antibody in dilution buffer overnight at 4°C. The embryos were washed in buffer 7 times for 30 min each, then in dilution buffer for 30 min. Next, they were incubated overnight with a fluorescein isothiocyanate-conjugated secondary antibody. The 
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Multiple independent-targeted clonal ES cell lines (6) carrying a Neo replacement in exon 13- (Fig. 1A) were isolated in three parental ES lines at an overall frequency of 1/35. These lines were confirmed to be heterozygous for the mutation by diagnostic Southern blot analysis (Fig. 1B) . Exon 13 is a nonalternatively spliced exon coding for part of the second fibronectin type III repeat in the extracellular domain (11) . This mutation results in a premature stop codon followed by a bovine growth hormone polyadenylylation signal. One of the mutant heterozygous lines was subjected to a second round of targeting using a puromycin replacement vector (Fig. 1A) to obtain a homozygous line. This was achieved at a frequency of 1/184 and was confirmed by diagnostic Southern blot analysis (Fig. 1B) . NCAM was not present on the surface of homozygous mutant ES cells induced to differentiate along a neuronal lineage (Fig. 1C) . By contrast, the culture medium from these neural cultures contained a secreted form of NCAM of the expected size (Fig. 1D) .
Heterozygous ES cells were used to generate 13 live-born founder chimeras (11 male and 2 female). Each animal con-tained a low contribution of ES cells as judged by coat color and Southern blot analysis (data not shown). Males were bred to C57BL/6 females, and 33 of 605 progeny were agouti. However, all of the progeny contained the wild-type Ncam allele. Although the mutant allele was determined to be present in testes by Southern blot analysis and in sperm by nested PCR (data not shown), this allele was not transmitted to viable offspring. These results suggested that fetuses carrying the mutation in the heterozygous state had died in utero.
To facilitate the investigation of this apparent dominant lethality, we created chimeric embryos with different levels of mutant ES contribution. Fetuses were dissected and analyzed between embryonic day (E) 8.5 and E10.5, the time at which NCAM begins to be expressed (12) . Approximately 6% of the embryos were found to be growth delayed or undergoing resorption (Table 1) , and this class of embryos contained greater than 90% ES cell contribution as shown by Southern blot analysis and scanning densitometry (data not shown). Moreover, the same degree of lethality was obtained with either heterozygous or homozygous ES cells and was observed with targeted clonal lines isolated from all three parental lines.
Abnormalities were first detected in chimeras with high ES cell contribution at E8.5. These embryos were truncated, and histologically the major initial defects were a reduced number of poorly formed somites and a kinking of the neural tube ( Fig.  2 A and B) . By E9.5, the mutant embryos exhibited an open anterior neuropore, small and irregular somites, and an absence of limb buds ( Fig. 2 C and D) . The abnormal differentiation of the mutant somites was also examined in terms of the expression patterns of N-cadherin and NCAM. In wild-type somites, N-cadherin expression was confined to the apical epithelial layer (Fig. 3A) (13) , whereas in mutant somites a broad diffuse pattern was observed (Fig. 3B) . With respect to NCAM in the heterozygote, which expresses both the membrane bound and secreted forms (Fig. 3D) , the pattern in all mutant somites resembled the distribution seen in nascent somites of wild-type embryos (Fig. 3C, left) . As expected for a soluble, secreted protein, the truncated NCAM in homozygous embryos resulted in a completely diffuse staining pattern throughout all tissues (Fig. 3E) .
The null (2) and 180 isoform (3) mutations of NCAM both resulted in fertile, viable progeny with distinct, localized defects in several differentiated tissues. In contrast, the present study shows that secretion of the extracellular domain of NCAM results in a dominant embryonic lethality with gross abnormalities in somitogenesis already evident by the end of gastrulation. Thus, it would appear that potent signals leading to abnormal somitogenesis can be generated by the presence of NCAM in the extracellular environment. A similar phenotype was reported in Xenopus embryos injected with RNA encoding the NCAM180 isoform (14) . Whereas the differences in the forms of the molecule and the method of experimental delivery make it difficult to compare these two studies directly, it would appear that similar signals can be produced by excessive expression of the extracellular domain in either a soluble or membrane-bound form. It may be noted that injection of RNA encoding only the extracellular domain of NCAM did not ellicit abnormal somitogenesis in the Xenopus embryo. However, this latter result may not be relevant because it appeared the truncated molecule was retained within the cytoplasm.
The fact that lethality was observed in the founder chimeras containing homozygous mutant ES cells, thus in the absence of membrane-bound NCAM, suggests that the secreted NCAM is producing this phenotype through a heterophilicrather than a homophilic-binding mechanism. While we cannot rule out the possibility of a nonspecific toxicity of the soluble NCAM itself, NCAM has been reported to participate in specific heterophilic interactions with extracellular matrix components such as collagens (15) , heparan sulfate (16, 17) , and chondroitin sulfate (18) proteoglycans, and with membrane-associated signaling molecules such as the Li adhesion molecule (19) and the fibroblast growth factor receptor (20) . It is therefore tempting to speculate that the formation of somites from paraxial mesoderm in the mutant is compromised by abnormal heterophilic interactions of NCAM that either affect migration of mesenchymal cells through the extracellular matrix or perturb signals linked to somite differentiation.
